Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study

Pemafibrate, a novel selective peroxisome proliferator-activated receptor modulator, has beneficial effects on lipid metabolism. However, its effects on glucose metabolism in individuals with type 2 diabetes (T2DM) remain to be fully clarified. This was a subanalysis of the PARM-T2D study, a multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomoto, Hiroshi, Kito, Kenichi, Iesaka, Hiroshi, Oe, Yuki, Kawata, Shinichiro, Tsuchida, Kazuhisa, Yanagiya, Shingo, Miya, Aika, Kameda, Hiraku, Cho, Kyu Yong, Sakuma, Ichiro, Manda, Naoki, Nakamura, Akinobu, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386707/
https://www.ncbi.nlm.nih.gov/pubmed/37514025
http://dx.doi.org/10.3390/pharmaceutics15071838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386707/
https://www.ncbi.nlm.nih.gov/pubmed/37514025
http://dx.doi.org/10.3390/pharmaceutics15071838

Ejemplares similares